Quarterly report pursuant to Section 13 or 15(d)

Marketable securities held (Details Narrative)

v2.4.1.9
Marketable securities held (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Portion of shares in escrow 600us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable
Sale of shares $ 5,400us-gaap_GainLossOnSaleOfEquityInvestments
Shares released 90us-gaap_StockRepurchasedDuringPeriodShares
Recognized loss on return of shares 584COCP_RecognizedLossOnReturnOfShares
Musclepharm repurchase of shares 250us-gaap_StockRepurchasedDuringPeriodValue
MusclePharm [Member]  
Common stock shares owned 260us-gaap_InvestmentOwnedBalanceShares
/ us-gaap_BusinessAcquisitionAxis
= COCP_MusclePharmMember
Price per share $ 10.00COCP_NonescrowedSharesPricePerShare
/ us-gaap_BusinessAcquisitionAxis
= COCP_MusclePharmMember
Fair value of escrowed Musclepharm securities $ 993COCP_FairValueOfEscrowedMusclepharmSecuritiesNet
/ us-gaap_BusinessAcquisitionAxis
= COCP_MusclePharmMember